Federal Testimonies

Explore recent testimonies, see transcripts and prepared statements made by members of the Johns Hopkins Drug Access and Affordability Initiative (JHDAAI) faculty in various committee hearings at the federal level.

  • Mariana Socal

    Testimony before the House Education and Labor Comittee / Subcommittee Hearing on "Making Health Care More Affordable:  Lowering Drug Prices and Increasing Transparency"  (September 26, 2019)
    View Website Link
    View PDF
     

  • Gerard Anderson

    Testimony before the House Committee on Energy and Commerce Subcommittee on Health on "Making Prescription Drugs More Affordable:  Legislation to Negotiate a Better Deal for Americans"  (September 25, 2019)
    View Website Link
    View PDF
     

  • Mariana Socal

    Testimony before the U.S. Food and Drug Administration on "The Future of Insulin Biosimilars:  Increasing Access and Facilitating the Efficient Development of Biosimilar and Interchangeable Insulin Products" (May 13, 2019)
    View Website Link
    View PDF
    View PowerPoint Slide
     

  • Mariana Socal

    Testimony before the U.S. Food and Drug Administration on "Facilitating Price Competition and Innovation in the Biological Products Marketplace Public Hearing" (September 4, 2018)
    View Website Link
     

  • Gerard Anderson

    Testimony before the U.S. Senate Committee on Health, Education, Labor, and Pensions Hearing on "The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay" (June 13, 2017)
    View PDF
     

  • Gerard Anderson

    Testimony before the U.S. House Committee on Oversight & Government Reform Hearing on "Examining the Impact of Voluntary Restricted Distribution Systems in the Pharmaceutical Supply Chain" (March 22, 2017)
    View PDF
     

  • Gerard Anderson

    Testimony before the U.S. Senate Special Committee on Aging Hearing on "Sudden Price Spikes in Off-Patent Drugs: Perspectives from the Front Lines" December 9, 2015
    View PDF